Esther Duperchy, PhD

Summit Plc
Abingdon, England, United Kingdom

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 730 - A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Ridinilazole Compared with Vancomycin for the Treatment of Clostridioides difficile Infection

  Thursday, October 20, 2022
  1:45 PM – 2:00 PM US ET